دورية أكاديمية

Protection against severe COVID-19 after second booster dose of adapted bivalent (original/Omicron BA.4-5) mRNA vaccine in persons ≥ 60 years, by time since infection, Italy, 12 September to 11 December 2022

التفاصيل البيبلوغرافية
العنوان: Protection against severe COVID-19 after second booster dose of adapted bivalent (original/Omicron BA.4-5) mRNA vaccine in persons ≥ 60 years, by time since infection, Italy, 12 September to 11 December 2022
المؤلفون: Fabiani M., Mateo-Urdiales A., Sacco C., Fotakis E. A., Rota M. C., Petrone D., Bressi M., Del Manso M., Siddu A., Fedele G., Stefanelli P., Bella A., Riccardo F., Palamara A. T., Rezza G., Brusaferro S., Pezzotti P., Boros S., Ceccarelli E., D'Ancona F. P., Di Benedetto C., Filia A., Urdiales A. M., Tallon M., Vescio M. F., Petrucci A., La Bianca M., Mignuoli A. D., Buono P., Massimiliani E., Barbone F., Vairo F., Sticchi C., Cereda D., Pompili M., Sforza F., Bertoli P., Benetollo P. P., Pasqualini C., Bisceglia L., Palmas M. A., Addario S. P., Balocchini E., Tosti A., Ruffier M., Da Re F., Battilomo S., Proietti V., Odio C., Recine M., Ruberto I., Ascione E Massimo Bisogno S., Miserendino G., Navacchia M., Del Frate B., Cau E., Baiocchi D., Fusco D., Gallo D., Marchetti M. R., Spazzafumo L., Malatesta R., Fanolla A., Conforti D., Trentini C., Ruggeri A., Ladalardo C., Albano N., Corona M., Lombardi P., Iacono M., Angori P. B., Belardinelli A., Solfiti M., Fioraso S., Poma C., Raccanello N.
المساهمون: Fabiani, M., Mateo-Urdiales, A., Sacco, C., Fotakis, E. A., Rota, M. C., Petrone, D., Bressi, M., Del Manso, M., Siddu, A., Fedele, G., Stefanelli, P., Bella, A., Riccardo, F., Palamara, A. T., Rezza, G., Brusaferro, S., Pezzotti, P., Boros, S., Ceccarelli, E., D'Ancona, F. P., Di Benedetto, C., Filia, A., Urdiales, A. M., Tallon, M., Vescio, M. F., Petrucci, A., La Bianca, M., Mignuoli, A. D., Buono, P., Massimiliani, E., Barbone, F., Vairo, F., Sticchi, C., Cereda, D., Pompili, M., Sforza, F., Bertoli, P., Benetollo, P. P., Pasqualini, C., Bisceglia, L., Palmas, M. A., Addario, S. P., Balocchini, E., Tosti, A., Ruffier, M., Da Re, F., Battilomo, S., Proietti, V., Odio, C., Recine, M., Ruberto, I., Ascione E Massimo Bisogno, S., Miserendino, G., Navacchia, M., Del Frate, B., Cau, E., Baiocchi, D., Fusco, D., Gallo, D., Marchetti, M. R., Spazzafumo, L., Malatesta, R., Fanolla, A., Conforti, D., Trentini, C., Ruggeri, A., Ladalardo, C., Albano, N., Corona, M., Lombardi, P., Iacono, M., Angori, P. B., Belardinelli, A., Solfiti, M., Fioraso, S., Poma, C., Raccanello, N.
بيانات النشر: European Centre for Disease Prevention and Control (ECDC)
سنة النشر: 2023
الوصف: Effectiveness against severe COVID-19 of a second booster dose of the bivalent (original/BA.4-5) mRNA vaccine 7-90 days post-administration, relative to a first booster dose of an mRNA vaccine received ≥ 120 days earlier, was ca 60% both in persons ≥ 60 years never infected and in those infected > 6 months before. Relative effectiveness in those infected 4-6 months earlier indicated no significant additional protection (10%; 95% CI: -44 to 44). A second booster vaccination 6 months after the latest infection may be warranted.
نوع الوثيقة: article in journal/newspaper
اللغة: English
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/36820640; info:eu-repo/semantics/altIdentifier/wos/WOS:000937437800002; volume:28; issue:8; numberofpages:7; journal:EUROSURVEILLANCE; https://hdl.handle.net/20.500.11768/157972Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85148772824; https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2023.28.8.2300105Test
DOI: 10.2807/1560-7917.ES.2023.28.8.2300105
الإتاحة: https://doi.org/20.500.11768/157972Test
https://doi.org/10.2807/1560-7917.ES.2023.28.8.2300105Test
https://hdl.handle.net/20.500.11768/157972Test
حقوق: info:eu-repo/semantics/openAccess
رقم الانضمام: edsbas.C003679C
قاعدة البيانات: BASE
الوصف
DOI:10.2807/1560-7917.ES.2023.28.8.2300105